The human multidrug resistance protein 4 (MRP4, ABCC4):: Functional analysis of a highly polymorphic gene

被引:89
作者
Abla, Nada [1 ]
Chinn, Leslie W. [1 ]
Nakamura, Tsutomu [1 ]
Liu, Li [1 ]
Huang, Conrad C. [2 ]
Johns, Susan J. [2 ]
Kawamoto, Michiko [2 ]
Stryke, Doug [2 ]
Taylor, Travis R. [2 ]
Ferrin, Thomas E. [2 ]
Giacomini, Kathleen M. [1 ]
Kroetz, Deanna L. [1 ]
机构
[1] Univ Calif San Francisco, Dept Biopharmaceut Sci, Sch Pharm, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA
关键词
D O I
10.1124/jpet.108.136523
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
ABCC4 encodes multidrug resistance protein 4 (MRP4), a member of the ATP-binding cassette family of membrane transporters involved in the efflux of endogenous and xenobiotic molecules. The aims of this study were to identify single nucleotide polymorphisms of ABCC4 and to functionally characterize selected nonsynonymous variants. Resequencing was performed in a large ethnically diverse population. Ten nonsynonymous variants were selected for analysis of transport function based on allele frequencies and evolutionary conservation. The reference and variant MRP4 cDNAs were constructed by site-directed mutagenesis and transiently transfected into human embryonic kidney cells (HEK 293T). The function of MRP4 variants was compared by measuring the intracellular accumulation of two antiviral agents, azidothymidine (AZT) and adefovir (PMEA). A total of 98 variants were identified in the coding and flanking intronic regions of ABCC4. Of these, 43 variants are in the coding region, and 22 are nonsynonymous. In a functional screen of ten variants, there was no evidence for a complete loss of function allele. However, two variants (G187W and G487E) showed a significantly reduced function compared to reference with both substrates, as evidenced by higher intracellular accumulation of AZT and PMEA compared to the reference MRP4 (43 and 69% increase in accumulation for G187W compared with the reference MRP4, with AZT and PMEA, respectively). The G187W variant also showed decreased expression following transient transfection of HEK 293T cells. Further studies are required to assess the clinical significance of this altered function and expression and to evaluate substrate specificity of this functional change.
引用
收藏
页码:859 / 868
页数:10
相关论文
共 41 条
  • [1] Expression of MRP4 confers resistance to ganciclovir and compromises bystander cell killing
    Adachi, M
    Sampath, J
    Lan, LB
    Sun, DX
    Hargrove, P
    Flatley, R
    Tatum, A
    Edwards, MZ
    Wezeman, M
    Matherly, L
    Drake, R
    Schuetz, J
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (41) : 38998 - 39004
  • [2] Pharmacogenetic characteristics of indinavir, zidovudine, and lamivudine therapy in HIV-infected adults: A pilot study
    Anderson, Peter L.
    Lamba, Jatinder
    Aquilante, Christina L.
    Schuetz, Erin
    Fletcher, Courtney V.
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2006, 42 (04) : 441 - 449
  • [3] Characterization of the human multidrug resistance protein containing mutations in the ATP-binding cassette signature region
    Bakos, E
    Klein, I
    Welker, E
    Szabo, K
    Muller, M
    Sarkadi, B
    Varadi, A
    [J]. BIOCHEMICAL JOURNAL, 1997, 323 : 777 - 783
  • [4] Multidrug resistance protein 4 protects bone marrow, thymus, spleen, and intestine from nucleotide analogue-induced damage
    Belinsky, Martin G.
    Guo, Ping
    Lee, Kun
    Zhou, Feng
    Kotova, Elena
    Grinberg, Alex
    Westphal, Heiner
    Shchaveleva, Irina
    Klein-Szanto, Andres
    Gallo, James M.
    Kruh, Gary D.
    [J]. CANCER RESEARCH, 2007, 67 (01) : 262 - 268
  • [5] Chen ZS, 2002, CANCER RES, V62, P3144
  • [6] The antiviral nucleotide analogs cidofovir and adefovir are novel substrates for human and rat renal organic anion transporter 1
    Cihlar, T
    Lin, DC
    Pritchard, JB
    Fuller, MD
    Mendel, DB
    Sweet, DH
    [J]. MOLECULAR PHARMACOLOGY, 1999, 56 (03) : 570 - 580
  • [7] Multidrug resistance-associated protein 4 is up-regulated in liver but down-regulated in kidney in obstructive cholestasis in the rat
    Denk, GU
    Soroka, CJ
    Takeyama, Y
    Chen, WS
    Schuetz, JD
    Boyer, JL
    [J]. JOURNAL OF HEPATOLOGY, 2004, 40 (04) : 585 - 591
  • [8] The human organic anion transporter 3 (OAT3; SLC22A8):: genetic variation and functional genomics
    Erdman, AR
    Mangravite, LM
    Urban, TJ
    Lagpacan, LL
    Castro, RA
    de la Cruz, M
    Chan, W
    Huang, CC
    Johns, SJ
    Kawamoto, M
    Stryke, D
    Taylor, TR
    Carlson, EJ
    Ferrin, TE
    Brett, CM
    Burchard, EG
    Giacomini, KM
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2006, 290 (04) : F905 - F912
  • [9] Variability in human hepatic MRP4 expression: influence of cholestasis and genotype
    Gradhand, U.
    Lang, T.
    Schaeffeler, E.
    Glaeser, H.
    Tegude, H.
    Klein, K.
    Fritz, P.
    Jedlitschky, G.
    Kroemer, H. K.
    Bachmakov, I.
    Anwald, B.
    Kerb, R.
    Zanger, U. M.
    Eichelbaum, M.
    Schwab, M.
    Fromm, M. F.
    [J]. PHARMACOGENOMICS JOURNAL, 2008, 8 (01) : 42 - 52
  • [10] AMINO-ACID DIFFERENCE FORMULA TO HELP EXPLAIN PROTEIN EVOLUTION
    GRANTHAM, R
    [J]. SCIENCE, 1974, 185 (4154) : 862 - 864